Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma
Fei Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhimin Lu(Zhejiang Chinese Medical University), Wei Guo(The University of Texas MD Anderson Cancer Center), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongfei Jiang(Qingdao University), Daqian Xu(Chinese Academy of Sciences), Xueli Bian(Xiamen University), Shuai Wang(Sichuan Agricultural University), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Gaoxiang Zhao(Qingdao University), Lei Zhu(Qingdao University), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dongming Xing(Qingdao University)
Cited by 18
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Lipid metabolism and cancer
|The Journal of Experimental Medicine|2020|981
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
|Journal of Biological Chemistry|2007|871
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501